AK

Anamika Kumari

Active Director Director DIN 10331972
DIN 10331972 First appointment Sep 2023 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Anamika Kumari

Data last updated:

Anamika Kumari is a Director at Arlan Pharmaceuticals Private Limited (since 2023). The company operates in Research & Development.

DIN 10331972
Primary Designation Director
Industry Research & Development
First Appointment 22 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Sep 20232023Active

Board colleagues of Anamika Kumari

NameDINCompanyDesignation
Pinki Singh10331973Arlan Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arlan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anamika Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anamika Kumari

Anamika Kumari currently holds 1 directorship: Arlan Pharmaceuticals Private Limited (Director, since 22 Sep 2023).

Anamika Kumari was first appointed on 22 Sep 2023 as Director at Arlan Pharmaceuticals Private Limited.

The current boards of Anamika Kumari's companies include Pinki Singh (Arlan Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available